References
- 1. INTERNATIONAL DIABETES FEDERATION. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org.
- 2. NCD RISK FACTOR COLLABORATION (NCD-RİSC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.
- 3. IKRAMUDDIN S, KORNER J, LEE WJ, CONNETT JE, INABNET WB, BILLINGTON CJ., et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.
- 4. ARTERBURN DE, BOGART A, SCHERWOOD NE, SIDNEY S, COLEMAN KJ., HANUSE S, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23(1):93–102.
- 5. SJOSTROM L, LINDROOS AK, PELTONEN M, TORGERSON J, BOUCHARD C., CARLSSONET B., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
- 6. AKKUS G, TETIKER T. Which predictors could effect on remission of type 2 diabetes mellitus after the metabolic surgery: A general perspective of current studies? World J. Diabetes. 2021;12(8):1312–24.
- 7. KHORGAMI Z, SHOAR S, ANDALIB A, AMINIAN A, BRETHAUER SA, SCHAUER PR. Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates. Surg Obes Relat Dis. 2017;13(5):774–8.
- 8. ANGRISANI L, SANTONICOLA A, IOVINO P, VITIELLO A, ZUNDEL N, BUCHWALD H., et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27(9):2279–89.
- 9. ZHANG R, BORISENKO O, TELEGINA I, AHMED AR, SANTOS RS, PRING C., et al. Systematic review of risk prediction models for diabetes after bariatric surgery. BJS. 2016;103(11):1420–7.
- 10. POPESCU AL, RADU IF, JINGA M, BALABAN VD, COSTACHE RS, SĂVULESCU F., et al. Impact of laparoscopic sleeve gastrectomy on esophageal physiology. Rom J Intern Med. 2021;59(3):296–302.
- 11. EXPERT COMMITTEE ON THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(1):5–20.
- 12. BUSE JB, CAPRIO S, CEFALU WT, CERİELLO A, DEL PRATO S, INZUCCHI SE., et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.
- 13. LEE WJ, HUR KY, LAKADAWALA M, KASAMA K, WONG SKH, CHENET SC., et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9(3):379–84.
- 14. STILL CD, BENOTTI P, MIRSHAHI T, COOK A, WOOD GC. DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission following metabolic surgery. Surg Obes Relat Dis. 2019;15(5):717–24.
- 15. ARON-WISNEWSKY J, SOKOLOVSKA N, LIU Y, COMANESHTER DS, VINKER S, PECHT T., et al. The advanced- DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017;60(10):1892–902.
- 16. PUCCI A, TYMOSZUK U, CHEUNG WH, MAKARONIDIS JM, SCHOLES S., THARAKAN G., et al. Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35(3):360–7.
- 17. LEE W-J, ALMULAIFI A, TSOU JJ, SER KH, LEE YC, CHEN SC. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015;11(5):991–6.
- 18. LEE W-J, CHONG K, AUNG L, CHEN SC, SER KH, LEE YC. Metabolic surgery for diabetes treatment: sleeve gastrectomy or gastric bypass? World J Surg. 2017;41(1):216–23.
- 19. CHEN J-C, HSU N-Y, LEE W-J, CHEN SC, SER KH, LEE YC. Prediction of type 2 diabetes remission after metabolic surgery: a comparison of the individualized metabolic surgery score and the ABCD score. Surg Obes Relat Dis. 2018;14(5):640–5.
- 20. CRAIG WOOD G, HORWITZ D, STILL CD, MIRSHAHI T, BENOTTI P, PARIKH M., et al. Performance of the DiaRem score for predicting diabetes remission in two health systems following bariatric surgery procedures in Hispanic and non-Hispanic white patients. Obes Surg. 2018;28(1):61–8.
- 21. FATIMA F, HJELMESÆTH J, HERTEL JK, SVANEVIK M, SANDBU R, SMASTUEN MC., et al. Validation of Ad-DiaRem and ABCD Diabetes Remission Prediction Scores at 1-Year After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in the Randomized Controlled Oseberg Trial. Obesity Surgery. 2022;32(3):801–809.
- 22. YANG PJ, SU YH, SHEN SC, LEE PC, LIN MT, LEE WJ., et al. Predictors of diabetes relapse after metabolic surgery in Asia. Surg Obes Relat Dis. 2022;18(4):454–63.
- 23. DICKER D, GOLAN R, ARON-WİSNEWSKY J, ZUCKER JD., SOKOLOWSKA N., COMANESHTER DS., et al. Prediction of long-term diabetes remission after RYGB, sleeve gastrectomy, and adjustable gastric banding using DiaRem and advanced-DiaRem scores. Obes Surg. 2019;29(3):796–804.
- 24. SHEN SC, WANG WEU, TAM KW, CHEN HA, LIN YK, WANG SY., et al. Validating Risk Prediction Models of Diabetes Remission After Sleeve Gastrectomy. Obes Surg. 2019;29(1):221–229.
- 25. DIXON J, HUR KY, LEE WJ, KIM MJ, CHONG K, CHEN SC., et al. Gastric bypass in type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabet Med. 2013;30(4):127–34.
- 26. HAYES MT, HUNT LA, FOO J, TYCHINSKAYA Y, STUBBS RS., et al. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg. 2011;21(7):910–6.
- 27. PARK JY, KIM YJ. Prediction of diabetes remission in morbidly obese patients after Rouxen-Y gastric bypass. Obes Surg. 2016;26(4):749–56.